Evidence map›Paper›PMID 29245962›Full record

ArticleOncotarget2017

Associations between

Zijie Wang, Ke Wang, Haiwei Yang, Zhijian Han, Jun Tao, Hao Chen, Yuqiu Ge, Miao Guo, Chuanjian Suo, Ji-Fu Wei and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Effect ofInternational journal of molecular sciences · 2024
    Article
  3. Review
  4. Article
  5. Oncotarget · 2018
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Zijie WangDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Ke WangDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Haiwei YangDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Zhijian HanDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Jun TaoDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Hao ChenDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Yuqiu GeSchool of Public Health, Nanjing Medical University, Nanjing, China.
Miao GuoResearch Division of Clinical Pharmacology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Chuanjian SuoDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Ji-Fu WeiResearch Division of Clinical Pharmacology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Ruoyun TanDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Min GuDepartment of Urology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-mediated rejection (ABMR) is a serious complications that can occur following renal transplantation. The production of donor-specific antibodies by the humoral immune response can trigger costimulatory signals, which are crucial in activating immune cells, and therefore, playing a potential role in ABMR. To investigate the role of

Indexed as

antibody-mediated rejectioncostimulatory signalskidney transplantationsingle-nucleotide polymorphisms next generation sequencing

Identifiers

PMID29245962
PMCPMC5725004
OpenAlexW2766253438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.